Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 21

1.

Expression of neutrophil gelatinase-associated lipocalin in colorectal neoplastic progression: a marker of malignant potential?

McLean MH, Thomson AJ, Murray GI, Fyfe N, Hold GL, El-Omar EM.

Br J Cancer. 2013 Jun 25;108(12):2537-41. doi: 10.1038/bjc.2013.264. Epub 2013 Jun 4.

2.

Lack of association between the rs2294008 polymorphism in the prostate stem cell antigen gene and colorectal neoplasia: a case-control and immunohistochemical study.

Smith C, Lochhead P, Basavaraju U, Hold GL, Fyfe N, Murray GI, El-Omar EM.

BMC Res Notes. 2012 Jul 23;5:371. doi: 10.1186/1756-0500-5-371.

3.

The inflammatory microenvironment in colorectal neoplasia.

McLean MH, Murray GI, Stewart KN, Norrie G, Mayer C, Hold GL, Thomson J, Fyfe N, Hope M, Mowat NA, Drew JE, El-Omar EM.

PLoS One. 2011 Jan 7;6(1):e15366. doi: 10.1371/journal.pone.0015366.

4.

Habitual dislocation of patella in knee disarticulation stump in a patient of congenital type I deficiency of tibia: a case report.

Desai MH, Fyfe N.

J Pediatr Orthop B. 2009 Nov;18(6):339-40. doi: 10.1097/BPB.0b013e32832feeff.

PMID:
19701103
5.

COX-2 expression in sporadic colorectal adenomatous polyps is linked to adenoma characteristics.

McLean MH, Murray GI, Fyfe N, Hold GL, Mowat NA, El-Omar EM.

Histopathology. 2008 Jun;52(7):806-15. doi: 10.1111/j.1365-2559.2008.03038.x. Epub 2008 May 6.

PMID:
18462368
6.

Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients.

Al-Mulla F, Hagan S, Behbehani AI, Bitar MS, George SS, Going JJ, GarcĂ­a JJ, Scott L, Fyfe N, Murray GI, Kolch W.

J Clin Oncol. 2006 Dec 20;24(36):5672-9.

7.

Expression of Fhit, cell adhesion molecules and matrix metalloproteinases in atypical adenomatous hyperplasia and pulmonary adenocarcinoma.

Kerr KM, MacKenzie SJ, Ramasami S, Murray GI, Fyfe N, Chapman AD, Nicolson MC, King G.

J Pathol. 2004 Jun;203(2):638-44.

PMID:
15141378
8.

Thyroid transcription factor 1 in pulmonary adenocarcinoma.

Stenhouse G, Fyfe N, King G, Chapman A, Kerr KM.

J Clin Pathol. 2004 Apr;57(4):383-7.

9.

Prosthetic rehabilitation of amputees aged over 90 is usually successful.

Graham LA, Fyfe NC.

Disabil Rehabil. 2002 Sep 10;24(13):700-1.

PMID:
12296985
10.

Combined shock-absorbing shin and dynamic response.

Graham LA, Fyfe NC.

Prosthet Orthot Int. 2000 Dec;24(3):246. No abstract available.

PMID:
11195361
11.

Effectiveness of rehabilitation following amputation.

Kent R, Fyfe N.

Clin Rehabil. 1999;13 Suppl 1:43-50. Review.

PMID:
10685622
12.

Follicular keratoses at amputation sites.

Ibbotson SH, Simpson NB, Fyfe NC, Lawrence CM.

Br J Dermatol. 1994 Jun;130(6):770-2.

PMID:
8011504
13.

Success rates for rehabilitation of vascular amputees: implications for preoperative assessment and amputation level.

Fyfe NC, Berridge DC.

Br J Surg. 1993 Jan;80(1):128. No abstract available.

PMID:
8498982
14.

Ranges of movement at the shoulder complex using an electromagnetic movement sensor.

Johnson GR, Fyfe NC, Heward M.

Ann Rheum Dis. 1991 Nov;50(11):824-7.

15.
16.

Bile peritonitis after removal of T-tubes from the common bile duct.

Corbett CR, Fyfe NC, Nicholls RJ, Jackson BT.

Br J Surg. 1986 Aug;73(8):641-3.

PMID:
3742179
17.
18.

The distribution of an oil-based corticosteroid following intralymphatic infusion.

Fyfe NC, Webb WA, Kinmonth JB.

Lymphology. 1984 Dec;17(4):130-4.

PMID:
6530900
19.

"Die-back" in primary lymphedema -- lymphographic and clinical correlations.

Fyfe NC, Wolfe JH, Kinmonth JB.

Lymphology. 1982 Jun;15(2):66-9.

PMID:
7109681
20.

Intralymphatic steroid therapy for lymphoedema: preliminary studies.

Fyfe NC, Rutt DL, Edwards JM, Kinmonth JB.

Lymphology. 1982 Mar;15(1):23-8.

PMID:
7070113
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk